Skip Content
You are currently on the new version of our website. Access the old version .
  • Tracked for
    Impact Factor
  • 2.4
    CiteScore
  • 40 days
    Time to First Decision

Endocrines, Volume 3, Issue 1

2022 March - 14 articles

Cover Story:

PBX1 is required for the differentiation of early progenitor cells into fetal Leydig cells in the mouse testis. From embryonic life to puberty, PBX1 is present in peritubular myoid cells (PMC, green line) and in interstitial cells, which includes progenitor and immature Leydig cells from the fetal (FLC, purple line) and adult (ALC, blue line) populations. PBX1 is absent from terminally differentiated FLC and ALC. In adults, PBX1 is found almost exclusively in Sertoli cells (SC, red line). The presence of PBX1 in different somatic cell populations during testicular development further supports a direct role for this transcription factor in testis cell differentiation and in male reproductive function. The yellow and blue areas represent fetal and post-natal life, respectively. View this paper

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Review
  • Open Access
4 Citations
15,572 Views
18 Pages

Genetic Disorders of Calcium and Phosphorus Metabolism

  • Assia Miller,
  • Serina Mathew,
  • Sneha Patel,
  • Lawrence Fordjour and
  • Vivian L. Chin

17 March 2022

In this review, we describe genetic mutations affecting metabolic pathways of calcium and phosphorus homeostasis. Calcium and phosphorus homeostasis has tight hormonal regulation by three major hormones: vitamin D, parathyroid hormone (PTH) and fibro...

  • Article
  • Open Access
3,109 Views
11 Pages

PRDX4 Potentially Predicts the Postoperative Outcome in Advanced Papillary Thyroid Carcinoma

  • Yuki Takaoka,
  • Xin Guo,
  • Akihiro Shioya,
  • Jia Han,
  • Yuzo Shimode,
  • Yoshiaki Kobayasi,
  • Morimasa Kitamura,
  • Hiroyuki Tsuji and
  • Sohsuke Yamada

17 March 2022

Background: Peroxiredoxin 4 (PRDX4), a secreted antioxidant enzyme, can protect against hepatocellular carcinoma and lung adenocarcinoma, but its role in papillary thyroid carcinoma (PTC) is still unclear. In this study, we investigated the associati...

  • Feature Paper
  • Review
  • Open Access
27 Citations
26,936 Views
12 Pages

Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders

  • Rossella E. Nappi,
  • Laura Cucinella,
  • David Bosoni,
  • Alessandra Righi,
  • Federica Battista,
  • Pietro Molinaro,
  • Giulia Stincardini,
  • Manuela Piccinino,
  • Roberta Rossini and
  • Lara Tiranini

16 March 2022

Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) encompass a variety of symptoms that occur during the luteal phase of the menstrual cycle and impair daily life activities and relationships. Depending on the type and severity of...

  • Review
  • Open Access
2 Citations
4,493 Views
12 Pages

Hyperinsulinism

  • Ethel Gonzales Clemente,
  • Shibani Kanungo,
  • Christine Schmitt and
  • Dana Maajali

16 March 2022

Congenital or monogenic hyperinsulinism (HI) is a group of rare genetic disorders characterized by dysregulated insulin secretion and is the most common cause of persistent hypoglycemia in children. Knowledge of normal glucose homeostasis allows for...

  • Review
  • Open Access
1 Citations
4,470 Views
8 Pages

Newborn Screening in Pediatric Endocrine Disorders

  • Martin Draznin,
  • Preeti Borgohain and
  • Shibani Kanungo

15 March 2022

Two endocrine disorders, congenital hypothyroidism (CH) and congenital adrenal hyperplasia (CAH), when untreated, can have devastating, irreversible and fatal outcomes. Permanent cognitive impairment, growth failure and dysmorphic appearance are seen...

  • Review
  • Open Access
5 Citations
10,244 Views
7 Pages

Relationship between Varicocele and Male Hypogonadism: A Review with Meta-Analysis

  • Giorgio Ivan Russo,
  • Maria Giovanna Asmundo,
  • Sarah Perelli,
  • Rosita A. Condorelli,
  • Aldo E. Calogero,
  • Rossella Cannarella and
  • Sandro La Vignera

1 March 2022

The relationship between varicocele and hypogonadism becomes clearer everyday thanks to the most recent literature, particularly with regards to the impact of varicocele repair on serum testosterone level improvement in hypogonadal patients. We selec...

  • Case Report
  • Open Access
1 Citations
6,226 Views
8 Pages

Diagnosis of Chromosome 15q-Terminal Deletion Syndrome through Elevated Fasting Serum Growth Hormone Levels

  • Masato Ono,
  • Masato Tanaka,
  • Shota Hiroshima,
  • Kentaro Sawano,
  • Yohei Ogawa,
  • Keisuke Nagasaki and
  • Akihiko Saitoh

23 February 2022

Chromosome 15q26-qter deletion syndrome is a rare disease that causes prenatal and postnatal growth retardation, microcephaly, developmental delay, and congenital heart diseases, mainly due to haploinsufficiency of IGF1R. In addition, patients with p...

  • Review
  • Open Access
5 Citations
7,434 Views
16 Pages

Multiple Endocrine Neoplasia in Childhood: An Update on Diagnosis, Screening, Management and Treatment

  • Marianne Jacob,
  • Dustin Rowland,
  • Oksana Lekarev and
  • Berrin Ergun-Longmire

17 February 2022

Multiple endocrine neoplasia (MEN) is a group of heterogenous syndromes characterized by the occurrence of two or more endocrine gland tumors in a patient or related individuals in the same family. They are inherited in an autosomal dominant fashion...

  • Feature Paper
  • Review
  • Open Access
4 Citations
9,520 Views
21 Pages

28 January 2022

According to current guidelines, growth hormone (GH) therapy is strongly recommended in children and adolescents with GH deficiency (GHD) in order to accelerate growth rate and attain normal adult height. The diagnosis of GHD requires demonstration o...

  • Article
  • Open Access
3 Citations
6,054 Views
10 Pages

Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study

  • Eleni Karlafti,
  • Triantafyllos Didangelos,
  • Emmanouil Benioudakis,
  • Evangelia Kotzakioulafi,
  • Georgia Kaiafa,
  • Vasileios Kotsis,
  • Antonios Ziakas,
  • Michail Doumas,
  • Antonios Goulas and
  • Christos Savopoulos

12 January 2022

Moxonidine is a centrally acting, anti-hypertensive medication that exerts additional metabolic properties. It is unknown whether its effects are mediated by neurotransmitters or sympathetic tone regulators, including Neuropeptide Y (NPY). In this st...

  • Review
  • Open Access
10 Citations
10,666 Views
14 Pages

Primary Hyperaldosteronism: When to Suspect It and How to Confirm Its Diagnosis

  • Jorge Gabriel Ruiz-Sánchez,
  • Mario Pazos Guerra,
  • Diego Meneses and
  • Isabelle Runkle

11 January 2022

The definition of primary hyperaldosteronism (PA) has shifted, as progress has been made in understanding the disease. PA can be produced by unilateral or bilateral cortical adrenal hyperproduction of aldosterone, due to hyperplasia, aldosterone-secr...

  • Article
  • Open Access
3 Citations
4,984 Views
13 Pages

Dynamic Expression of the Homeobox Factor PBX1 during Mouse Testis Development

  • Vanessa Moisan,
  • Catherine Brousseau and
  • Jacques J. Tremblay

5 January 2022

Members of the pre-B-cell leukemia transcription factor (PBX) family of homeoproteins are mainly known for their involvement in hematopoietic cell differentiation and in the development of leukemia. The four PBX proteins, PBX1, PBX2, PBX3 and PBX4, b...

  • Review
  • Open Access
6 Citations
6,140 Views
15 Pages

24 December 2021

Idiopathic hypogonadotropic hypogonadism (IHH) is a group of rare developmental disorders characterized by low gonadotropin levels in the face of low sex steroid hormone concentrations. IHH is practically divided into two major groups according to th...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Endocrines - ISSN 2673-396X